# HSEF v5.3 review: Chromatin Accessibility = Transcriptional Competence > Sources: 61 primary reports; claims: 66; verified: 66; unverified: 0. Verification is bounded attribution. Access: 6 partial-body and 55 bounded abstract/status examinations. Literature cutoff: 2026-10-09; source examination UTC date: 2026-10-12. No complete-paper audit or blinded calibration claimed. > **Adversarial review:** Generated by Sol 6.1; adversarially reviewed by Claude Opus 5.5 (Anthropic) on 2026-10-14. 3 corrections applied (see ADVERSARIAL REVIEW AND APPROVAL). Status: **Approved as revised.** ## AT A GLANCE **Accessible chromatin predicts regulatory activity, but access alone neither guarantees transcription nor supplies a universal upstream mechanism of competence.** | Level | Confidence | Causal role | Momentum | Stability | Divergence | |---|---|---|---|---|---| | Γ — Mechanistically plausible, partial system support | Moderate | reinforcing / stabilizing factor | Mechanistic only | Stable | Contested | **Deciding experiment:** At prespecified native promoters/enhancers, alter DNA accessibility with an orthogonal state intervention while preserving factor occupancy, activation domains, acetylation/coactivators and polymerase function as far as possible. Apply a matched activating stimulus and measure initiation/bursting with calibrated nascent RNA and single-fiber accessibility. Restore only the accessible state in a matched rescue; retain a dead-HAT opening-without-activation control. Verify cell-cycle distribution, replication stress, viability, target-factor abundance and local cis sequence across developmental/replication windows. **Belief versus evidence:** Overall Γ follows the preregistered primary necessity SC2: strong endogenous remodeler/factor causality exists, but necessity of the measured accessible state itself remains incompletely isolated. SC1 correlation is Β. Broad sufficiency SC3 and universal upstream SC4 are each Β after one-rung falsification downgrades from partial Γ. The alternative aggregation rules would return Β weakest-link and Γ primary/scope-matched. **Best-supported rival:** Polymerase-remodeler-factor cooperation. At the endogenous asb11 locus in NPS-null embryos, catalytic-dead HAT restores accessibility but not transcription, whereas active HAT restores both (PMID35182480). Together with paused-polymerase stabilization of BAF and ATPase-dependent eviction (PMID38049663), this separates a sufficient-accessibility switch from specific cooperative activation. It does not prove that every locus uses the same cooperation or that accessibility is dispensable. ## COMPETING MECHANISTIC MODELS **Rank 1: Polymerase-remodeler-factor cooperation (Ε).** Paused polymerase, ATP-dependent remodelers and sequence-specific factors jointly stabilize locus-specific accessible states and transcription. Stage-specific inhibitors with calibration, ATPase-blocked intermediate retention and EP400 compensation map causal cooperation within specified cultured-cell settings. This is not every developmental state: most early zebrafish opening persists without polymerase transcription; global inhibitors and multiple protein functions require timing controls. **Rank 2: Pioneer and coactivator specificity (Ε).** Sequence-specific factors and their recruited coactivators carry regulatory specificity and can create or exploit accessible states. NPS mutants with targeted active-HAT rescue, OCT4/BRG1 dependence, domain/motif contrasts and productive/unproductive pioneer sites establish restricted factor/cofactor causality. Factor labels are not universal categories; some nonclassical factors pioneer, and opening can occur without transcription. **Rank 3: Permissive accessibility with activation inputs (Γ).** Accessibility permits selected regulatory interactions but additional activating inputs determine output. Open-before-transcription priming and dead-HAT opening without activation favor permissiveness rather than a sufficient switch. The necessity of accessibility as an independently measured state has not been cleanly established across the registered scope. **Rank 4: Transcription-produced accessibility in defined contexts (Ε).** Initiation, pausing or upstream transcription builds or maintains open chromatin in specified windows. Postreplication restart, local ncRNA terminator tests and polymerase/BAF synergy support restricted reverse-direction mechanisms. This cannot replace all accessibility biology because polymerase-independent developmental opening is verified. **Rank 5: Accessibility directly determines competence (Γ).** Measured open chromatin universally defines loci available for transcription and directs activation upstream. Robust correlations, acute BAF dependence and temporal priming provide partial support. Multifunctional mediator perturbations, opening-only failure and reverse-direction contexts prevent the registered causal generalization. The tournament does not alter the nominal level. Compatible pathways and flexible alternatives are not automatically proved by explaining observations. ## FULL REVIEW ### Registered claim and scope Chromatin accessibility determines transcriptional competence, such that accessible loci are those available for transcription. Index primary-subclaim SC2 retained. Necessity of accessibility itself is separated from multifunctional remodeler or factor necessity. Selection: remaining-priority list position 17 from the editorial list of 2026-10-09. Registered claim assessed against original sources. Any carried-forward edition and prior visibility are recorded in the change record; no independent blinded calibration is claimed. ### Evidence and causal interpretation Rubric fit: 03 directly applies. The accessible state is an assay-dependent regulatory feature, not identical to absence of every nucleosome or large-scale chromatin decondensation. Native-locus, degron, drug, calibrated accessibility and nascent-transcription evidence is retained; gene/protein necessity is not silently recast as state necessity. Competence is potential to respond, which must be tested with a controlled activating challenge; baseline RNA absence at an open site alone is not a competence failure. The SC3 catalytic-dead-HAT test concerns actual activation sufficiency, a separate registered subclaim. Accessibility is predictive but is not a binary label for every regulatory step. Cancer, adult-mouse and fetal-human atlases reveal extensive cell-type patterns and candidate gene links. These original data support SC1 correlation, not an independent intervention on competence. Single-fiber measurements reveal focal intranucleosomal access, so a nucleosome-covered site need not be physically inaccessible to every factor. Conversely, a bulk open peak does not guarantee an activation signal. PMID30361341; PMID30078704; PMID33184180; PMID42056506; PMID39208807. Consensus proposed two useful primary leads, which were checked against original abstracts and added: ATAC-STARR testing reports activating and silencing potential among accessible regions, but is a reporter assay rather than native competence; the published 2023 Drosophila study separates Zelda-dependent priming from patterning-factor activation using genetic validation. The provider's2022 label for the latter is not used as the published original date. PMID35858748; PMID37557175. Acute BAF experiments improve the causal evidence substantially. Endogenous BRG1-AID mice have unchanged baseline protein levels and no measured growth/viability defect in the experimental window; nascent RNA changes exceed those seen in steady-state RNA. The 2021 dTAG clone, however, begins with approximately 50% SMARCA4 and baseline chromatin changes. Under nontoxic ATPase inhibition, ATAC effects appear within minutes while few regions have strong early PRO-seq changes. This does not erase mediator causality, but it prevents equating every early lost ATAC peak with immediate loss of competence. PMID38811575; PMID33558760; PMID34731603. Compensation and dose reveal boundaries. At many promoters, EP400 restores accessibility and gene activity during prolonged SWI/SNF inhibition; selected enhancers/promoters remain dependent. Where ATAC rises above control, transcription is not broadly above control. The original reports appropriate early morphology/proliferation controls and EP400 knockdown viability controls. BRG1 dosage experiments likewise show buffered transcription and different promoter/enhancer sensitivities. None selectively removes accessibility while preserving all protein/coactivator functions. PMID37922899; PMID40846763. An especially discriminating native-locus test concerns sufficiency. In NPS-null zebrafish, active dCas9-HAT rescues acetylation and transcription of target genes with untargeted and catalytic-dead controls. Catalytic-dead dCas9-HAT restores asb11 accessibility without restoring acetylation or transcription. This is stronger than merely observing a silent open peak: the manipulated opening fails to activate. It updates the index's older generalization that no experiment separates accessibility from its producer, while leaving universal necessity unresolved. Active-HAT bypass is not opening-only sufficiency. PMID35182480; PMID25849900; PMID35271371. Direction is contextual. Most zebrafish ZGA opening persists after alpha-amanitin treatment and precedes activation; hypertranscribed miR430 is the documented exception. In mammalian postreplication chromatin, transcription restart instead contributes to restored accessibility. Paused RNAPII stabilizes BAF occupancy, and ATPase inhibition retains partially unwrapped nucleosomes. Triptolide controls show preserved morphology/viability up to 2 hours but defects by 4 hours, so early findings cannot license every late sample. Local yeast ncRNA transcription and polymerase footprints add reverse-direction mechanisms. PMID31940339; PMID31126739; PMID38049663; PMID18820678; PMID39191261. Sequence-specific and additional activation inputs carry specificity. OCT4/BRG1, PARP1/Sox2 and domain/motif tests identify mechanisms of selective factor access. Induced pioneer experiments include productive and unproductive sites and are capped for endogenous generalization. PBAF can provide accessibility for REST-mediated repression, while p300 catalytic activity governs transcriptional initiation beyond TF recruitment. METTL3/RNA-stability work uncouples direct chromatin-target accessibility from RNA output. These findings support cooperative or permissive models rather than a universal accessibility switch. PMID28287392; PMID28212747; PMID40479714; PMID40252649; PMID33765415; PMID41135527. Consensus supplied a useful mechanistic comparison and gap/timeline leads, but it did not retrieve several original anchors already examined here. Original checks restore the EP400 recovery detail, most polymerase-independent zebrafish priming, and the catalytic-dead-HAT opening-without-activation contrast. Provider-selected articles or evidence-matrix cells are not the 61 examined primary reports or proof of field-wide absence. Scite was not retried after the recorded account-wide quota failure in the concurrent review. ## HYPOTHESIS STATE EVALUATION FRAMEWORK (HSEF v5.3) ### Subclaim matrix and aggregation | Subclaim | Scope | Level | Decision | |---|---|---|---| | SC1 Accessibility and transcription are correlated. | Endogenous locus, cell state, temporal resolution and intervention specified before outcomes | Β | Accessibility and transcriptional state correlate extensively across original atlases, cell types and time courses. This existence subclaim is associational, with measurement scale, cell mixtures, motif sequence and transcriptional feedback affecting the correlation. Predictive accuracy does not establish causal direction. | | SC2 An accessible state is necessary for transcriptional competence. | Endogenous locus, cell state, temporal resolution and intervention specified before outcomes | Γ | Acute endogenous remodeler perturbations and functional nascent-RNA readouts supply important mechanistic support. Yet they also perturb ATPase activity, transcription-factor occupancy, coactivator recruitment and nucleosome states; they do not establish that the accessible state as measured is universally necessary for transcriptional competence independently of those functions. The registered SC2 remains Γ. This does not mean physical DNA access is irrelevant or that remodelers lack endogenous causal effects. | | SC3 Accessibility is sufficient to activate transcription. | Endogenous locus, cell state, temporal resolution and intervention specified before outcomes | Β | Opening alone is insufficient in a directly informative native-locus test: catalytic-dead dCas9-HAT restores asb11 accessibility in NPS-null zebrafish without restoring acetylation or transcription, while active HAT restores both. Promoter ATAC recovery above control also need not increase transcription above control. Positive active-HAT or ectopic-TF activation tests change more than opening. The broad sufficiency subclaim begins with Γ partial support and is downgraded one rung to Β by the specific opening-without-output falsification; Β is not a declaration that all opening is nonfunctional. | | SC4 Accessibility is causally upstream of transcription. | Endogenous locus, cell state, temporal resolution and intervention specified before outcomes | Β | Opening can precede transcription during zebrafish genome activation, but postreplication transcription restart, paused-polymerase/BAF cooperation and local ncRNA transcription can instead generate or stabilize accessibility. The registered general upstream direction therefore cannot be universal. Partial Γ directional support is downgraded one rung to Β for verified direction-reversal contexts, rather than describing them as merely missing evidence. | Preregistered aggregation: primary-subclaim. Overall Γ follows the preregistered primary necessity SC2: strong endogenous remodeler/factor causality exists, but necessity of the measured accessible state itself remains incompletely isolated. SC1 correlation is Β. Broad sufficiency SC3 and universal upstream SC4 are each Β after one-rung falsification downgrades from partial Γ. The alternative aggregation rules would return Β weakest-link and Γ primary/scope-matched. Sensitivities: weakest-link Β; primary-subclaim Γ; scope-matched Γ. ### Decisive-perturbation inventory and causal tally [1] Endogenous BRG1-AID depletion reduces nascent RNA, RNAPII occupancy and DHS accessibility in primary mouse cells without measured viability/growth defects. BRG1 loss also changes nucleosomes, p300 and acetylation; it does not selectively remove accessible state while preserving other mediator functions. [3] dTAG, ATPase inhibition and degradation rapidly alter BAF-dependent accessibility with smaller early PRO-seq changes under nontoxic inhibitor conditions. dTAG clone begins with about 50% SMARCA4 and baseline changes; rapid accessibility loss is not a selectively isolated state perturbation or immediate global loss of transcription. [4] Chemical-genetic time courses show paused RNAPII stabilizes BAF occupancy and ATPase-dependent eviction; TF binding confers locus specificity. Inhibition changes transcription machinery directly; ≤2 h triptolide viability controls do not extend to 4 h, and bidirectional synergy is not universal upstream opening. [5] Fast SWISNF inhibition reduces accessibility/transcription; EP400 restores promoter accessibility and expression during prolonged inhibition, with no toxicity in early windows. Above-control ATAC recovery need not increase transcription above control; factor activity and state remain coupled despite orthogonal inhibitor/degrader/EP400 tests. [7] p300/CBP catalytic activity controls rapid PIC/RNAPII recruitment and pause release while TF/coactivator recruitment persists. This isolates acetylation-dependent activation, not accessibility-only necessity; original body was not publicly retrieved in this audit. [9] Zebrafish regulatory opening precedes transcription and persists under alpha-amanitin except miR430; maternal-factor loss reduces opening. Priming is not sufficient activation; transcription independence in this window is not universal across replication/cell states, and nearest-neighbor enhancer links are inferred. [10] NPS-null zebrafish have lost enhancer opening; locus dCas9 active HAT restores transcription, while catalytic-dead HAT restores opening without transcription at asb11. Clean opening-without-activation discriminates sufficiency but does not prove a universal necessity of measured ATAC; targeted HAT also changes acetylation/cofactor recruitment. [11] Postreplication transcription restart is required to restore active chromatin accessibility in mouse ESCs by repli-ATAC and transcription inhibition. Replication-conditioned restoration is not every locus/state; linked erratum PMID31348880 was identified but its details were not read. Tally: 0 positive qualifying study units across scoped subclaims; 53 screened discriminating contrast units. These are not independent causal lines or proof of full-claim necessity/sufficiency. Null and negative contrasts are discriminators, not positive threshold crossings. Reports and replications are not independent causal lines. Reports sharing participants, models or instruments are not independent causal lines. Pivotal nulls do not earn positive threshold crossings. No positive field-valid crossing was verified for the registered causal scope in this bounded audit. The proposed registered experiment makes that scope testable. Pivotal symptom studies remain informative; missing registration or mediator verification is an audit limitation, not evidence that dopamine has no effects or that antipsychotics lack efficacy. ### Cap audit, precedence and Β/Γ/Δ boundary Endogenous factor/remodeler, locus-HAT and polymerase manipulations retain their actual causal scopes and are not re-capped as merely descriptive association. The nominal feature is measured accessibility itself: positive multifunctional mediator results cannot automatically cross its necessity threshold. Artificial TF expression, biochemical reconstitution, simulations and BAC transgenes retain universal/model limits. Direct opening-without-transcription and reverse-direction tests constrain specific nominal subclaims, not the existence of chromatin regulation generally. Nascent RNA is a functional transcription endpoint, rather than a disease biomarker, but global collapse controls remain necessary. Universal six-cap audit: All six universal caps were considered: cell-only inference, unperturbed association, ectopic expression, biomarker-only intervention, forced transfer/seeding, and inherited-to-sporadic scope transfer. Each binds its offered inference; complementary same-scope causal classes are assessed together rather than re-capped in isolation. Gamma hard-rule audit: ATAC/DNase/motif atlases alone are Β-limited for causality. Reporter-only and in-vitro/simulation results cannot establish endogenous state necessity. Acute endogenous BAF tests improve timing and viability controls but alter multiple mediator functions; bulk state-specific necessity remains unresolved. Global transcriptional inhibition has intended transcriptional effects and can acquire viability/replication stress with time; early controls do not justify all late samples. Targeted active versus dead HAT separates opening from activation in a named locus; this clean sufficiency-negative test updates the index's older generalized claim that no state separation exists. SC1 cap: “Pure association evidence — however large, however replicated — cannot exceed Β.” Accessibility and transcriptional state correlate extensively across original atlases, cell types and time courses. This existence subclaim is associational, with measurement scale, cell mixtures, motif sequence and transcriptional feedback affecting the correlation. Predictive accuracy does not establish causal direction. SC2 cap: “Mechanistic plausibility plus in vitro reconstitution or simplified cellular support caps at Γ.” Acute endogenous remodeler perturbations and functional nascent-RNA readouts supply important mechanistic support. Yet they also perturb ATPase activity, transcription-factor occupancy, coactivator recruitment and nucleosome states; they do not establish that the accessible state as measured is universally necessary for transcriptional competence independently of those functions. The registered SC2 remains Γ. This does not mean physical DNA access is irrelevant or that remodelers lack endogenous causal effects. SC1 field-valid definition: “ - Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype - Locus-specific disruption of looping with locus-specific effect - Combinatorial histone-mark perturbation showing direct output dependence - Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: no. Accessibility and transcriptional state correlate extensively across original atlases, cell types and time courses. This existence subclaim is associational, with measurement scale, cell mixtures, motif sequence and transcriptional feedback affecting the correlation. Predictive accuracy does not establish causal direction. SC2 field-valid definition: “ - Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype - Locus-specific disruption of looping with locus-specific effect - Combinatorial histone-mark perturbation showing direct output dependence - Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: no. Acute endogenous remodeler perturbations and functional nascent-RNA readouts supply important mechanistic support. Yet they also perturb ATPase activity, transcription-factor occupancy, coactivator recruitment and nucleosome states; they do not establish that the accessible state as measured is universally necessary for transcriptional competence independently of those functions. The registered SC2 remains Γ. This does not mean physical DNA access is irrelevant or that remodelers lack endogenous causal effects. SC3 field-valid definition: “ - Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype - Locus-specific disruption of looping with locus-specific effect - Combinatorial histone-mark perturbation showing direct output dependence - Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: no. Opening alone is insufficient in a directly informative native-locus test: catalytic-dead dCas9-HAT restores asb11 accessibility in NPS-null zebrafish without restoring acetylation or transcription, while active HAT restores both. Promoter ATAC recovery above control also need not increase transcription above control. Positive active-HAT or ectopic-TF activation tests change more than opening. The broad sufficiency subclaim begins with Γ partial support and is downgraded one rung to Β by the specific opening-without-output falsification; Β is not a declaration that all opening is nonfunctional. SC4 field-valid definition: “ - Endogenous degron of a condensate component with matched rescue, AND evidence that the specific condensate state (not generic protein loss) drives the phenotype - Locus-specific disruption of looping with locus-specific effect - Combinatorial histone-mark perturbation showing direct output dependence - Critically: specificity against cell-cycle collapse, global transcriptional collapse, and replication stress must be demonstrated” Positive full-scope result: no. Opening can precede transcription during zebrafish genome activation, but postreplication transcription restart, paused-polymerase/BAF cooperation and local ncRNA transcription can instead generate or stabilize accessibility. The registered general upstream direction therefore cannot be universal. Partial Γ directional support is downgraded one rung to Β for verified direction-reversal contexts, rather than describing them as merely missing evidence. ### Upward threshold ladder SC1 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: no. A causal subclaim needs an orthogonal locus-specific intervention rather than adding more atlas correlations; the correlation-existence claim itself does not require a higher causal level. SC2 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: no. At native loci, independently reduce or restore measured accessibility while preserving sequence-specific factors, acetylation/coactivators and polymerase competence, then apply the same activating stimulus and measure initiation/bursting. Match rescue and verify cell cycle, replication stress, factor abundance and viability. SC3 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: no. Prospectively define loci/cell states and selectively open them without recruiting activation domains or changing coactivator/histone activity, with matched opening controls and direct nascent-transcription readout. Include the known open-without-activation control and do not redefine scope as responsive loci. SC4 Δ: “Requires at least one endogenous perturbation showing the proposed feature contributes causally to the claimed output.” Satisfied: no. Establish time-resolved state-specific opening before initiation at native loci, separate pausing/initiation/elongation with orthogonal methods, and prospectively map developmental versus replication and stimulus contexts; retain reverse-direction counterexamples. Upper ladder: Orthogonal endogenous degrons and ATPase inhibitors, factor-domain/motif contrasts, targeted HAT rescue, nascent-RNA assays, calibrated single-fiber state measurements and allele-associated regulatory variants were considered. These establish valuable mediator mechanisms in different contexts, but not independent same-scope necessity of accessibility alone. Higher levels remain reachable with a selective endogenous state manipulation and prespecified competence challenge rather than more ATAC correlation. Independence: Assay classes and systematic failure modes are distinguished. Replicate loci, degron/inhibitor versions of one mediator and multiple papers from one factor/cell resource do not by themselves create independent causal lines. Zebrafish NPS reports share factors/developmental system, though the targeted-HAT experiment adds a different discriminator. A preprint and its published/update version count once.61 reports are not 59 independent mechanisms. Acute remodeler and dosage perturbation [1, 3, 5, 6]: Reduce chronic adaptation and selected viability alternatives, while shared ATPase/complex functions still confound state mediation. Developmental factor loss and targeted catalytic rescue [9, 10, 8]: Constrain sequence-factor/coactivator mechanisms and opening-only sufficiency; developmental settings and artificial targeted constructs retain scope. Transcription-stage and replication direction tests [4, 11, 47, 12]: Constrain a universal upstream-opening account using different timing/locus/fiber assays; broad inhibitor and local cis effects remain. Single-cell/fiber and genetic measurement [30, 33, 25, 39]: Constrain broad correlations and assay scale, not accessibility-specific necessity or sufficiency. ### Falsification and pitfalls Perturbing the proposed feature leaves the claimed output intact or opening fails to activate. SC3: catalytic-dead HAT restores opening without transcription at asb11 (PMID35182480), and elevated promoter ATAC does not produce broadly above-control transcription (PMID37922899). Preliminary Γ→Β for broad sufficiency. Additional downgrade: True. Alternative direction contradicts universal upstream primacy. SC4: postreplication restart, polymerase/BAF pausing and upstream ncRNA transcription can generate/stabilize access (PMID31126739, PMID38049663, PMID18820678), while early zebrafish priming retains the opposite direction. Preliminary Γ→Β for universal primacy. Additional downgrade: True. Accessibility treated as competence. An assay peak is not a standardized response potential or an activation signal. Mediator necessity becomes state necessity. BRG1/BAF/TF loss changes multiple functions, even with acute timing controls. Universal direction inferred from one window. Zebrafish priming and mammalian postreplication restart have different causal ordering. Reporter or structural result promoted. BAC arrays, motif integrations, simulations and reconstituted nucleosomes retain model limits. Nascent and stable RNA conflated. Short perturbations can have large PRO-seq effects and small steady-state RNA changes. ### Adversarial steelman: above, then below One rung above, Δ: acute endogenous BRG1 or BAF loss rapidly reduces accessibility and nascent transcription without immediate viability collapse, and many promoters recover both through EP400. These are credible endogenous mediator effects. The blocker for registered SC2 is that DNA-state necessity has not been isolated from remodeler/TF/coactivator functions with a matched competence challenge and state-specific rescue. One rung below, Β: accessible-state maps are correlated with transcription and many manipulations hit multifunctional factors. But endogenous time-resolved, calibrated perturbations and locus-specific controls supply substantial mechanistic content beyond atlas association, supporting Γ partial state-mechanism evidence. Retain Γ for necessity with explicit separation from mediator causality. Reject both a universal open-locus transcription switch and a dismissal of endogenous remodeler/chromatin causal experiments. ### Final score, causal direction and M/S/D Overall Γ follows the preregistered primary necessity SC2: strong endogenous remodeler/factor causality exists, but necessity of the measured accessible state itself remains incompletely isolated. SC1 correlation is Β. Broad sufficiency SC3 and universal upstream SC4 are each Β after one-rung falsification downgrades from partial Γ. The alternative aggregation rules would return Β weakest-link and Γ primary/scope-matched. Transcription can generate accessibility in some contexts, while factor/remodeler-dependent opening precedes and supports activation in others; the inventory does not support a purely downstream account everywhere. Co-variation alone is inadequate, but mediator and targeted state comparisons demonstrate mechanistic involvement. Universal accessible-state initiation/rate limitation and requirement are not independently established. Step 5 therefore treats measured accessibility provisionally as a context-dependent supporting state in feedback with upstream factors and transcription, with the more specific permissive necessity model separately scored Γ. Momentum: Mechanistic only. Recent BRG1 dosage/degron work (PMID40846763), native nucleosome-domain/fiber experiments (PMID42056506), PBAF/REST specificity (PMID40252649) and METTL3 accessibility-output uncoupling (PMID41135527) test mechanisms and state boundaries. They do not yet supply a selective universal accessible-state necessity experiment. Stability: Stable. No verified named pending state-selective necessity/rescue result was identified in this bounded search. A registered native-state perturbation with controlled activating challenge could raise SC2; further opening-only failures or reverse-direction studies could refine its scope. Divergence: Contested. No manufactured field consensus or arithmetic gap. These dimensions do not change level or confidence. ## PROPOSED DECISIVE EXPERIMENTS At prespecified native promoters/enhancers, alter DNA accessibility with an orthogonal state intervention while preserving factor occupancy, activation domains, acetylation/coactivators and polymerase function as far as possible. Apply a matched activating stimulus and measure initiation/bursting with calibrated nascent RNA and single-fiber accessibility. Restore only the accessible state in a matched rescue; retain a dead-HAT opening-without-activation control. Verify cell-cycle distribution, replication stress, viability, target-factor abundance and local cis sequence across developmental/replication windows. Readout: Direct nascent transcription/burst initiation after a matched competence challenge, alongside calibrated bulk and single-fiber DNA access. Controls: State-specific matched rescue, target/untarget loci, catalytic-dead and recruitment controls, unchanged sequence/factor/coactivator abundance, cell cycle, replication stress, viability and timing. Supporting: Selective closure blocks the prespecified response and restoring access alone rescues it without restoring other regulator functions; prospectively repeat across distinct native loci/states. Falsifying: Adequate state manipulation leaves competence intact, restoration changes only assay signal, or output follows changed coactivator/factor function rather than the measured state. ## KNOWLEDGE GAPS A selective accessible-state necessity intervention must preserve the multifunctional regulators that establish it. Competence requires a standardized activating challenge and cannot be inferred from either basal ATAC or basal RNA alone. Bulk ATAC/DNase, methylase footprinting, local nucleosome distortion and large-scale decondensation measure different aspects of access. Temporal direction depends on developmental, replication and stimulus context; a universal upstream or downstream account fails. Specificity of factor/remodeler perturbations must exclude cell-cycle, viability, replication stress and transcriptional-collapse alternatives at each sampled time. Opening-only sufficiency fails at named loci, while acetylation/coactivator rescue can work; these need independent locus/state replication. Preprint/update duplication, shared reagents and repeated loci must be distinguished from independent error classes. ## REVIEWER NOTES Original primary abstracts/status records and selected body passages were examined. Most full papers and supplements were not audited. Consensus browser synthesis supplements discovery and original-source reconciliation. No independent blinded grading or scientific peer review is claimed. Search leads, reviews, protocols and correction notices do not pad the primary count. Downloaded XML does not earn examination credit. Linked notices remain attached; unexamined correction details limit inference. This is a coordinator source/claim consistency assessment, not independent blinded calibration. ## Consensus and original-source reconciliation Provider said this original was unavailable. Actual original Results 1/2/6/8/25/26 show early SWI/SNF inhibition loses accessibility and transcription; EP400 restores both at many promoters. Above-control ATAC in clusters 3/4 does not yield broadly above-control transcription. Do not describe every recovered promoter as failing expression recovery or provider search absence as a field gap. [Original PMID37922899](https://pubmed.ncbi.nlm.nih.gov/37922899/). Provider did not retrieve this original. Results2/4/7/12 show most early zebrafish opening persists under alpha-amanitin and precedes gene activation. Hypertranscribed miR430 loses opening, a specific exception. No universal statement that all accessibility requires transcription or that transcription is irrelevant is justified. [Original PMID31940339](https://pubmed.ncbi.nlm.nih.gov/31940339/). Provider describes active-HAT bypass but omits the decisive control. Original Results 7/8 show catalytic-dead dCas9-HAT restores asb11 opening without acetylation or transcription; active HAT rescues target transcription with untargeted/catalytic controls. HAT bypass does not mean opening itself is sufficient or bypassed. [Original PMID35182480](https://pubmed.ncbi.nlm.nih.gov/35182480/). Original Results2/3/9/14 support paused RNAPII stabilizing BAF and ATPase-dependent nucleosome eviction. Triptolide shows no morphology/viability change up to 2 hours but defects at 4 hours, so early controlled evidence cannot license all late samples. PRC2-repressed and H3K9me3 constitutive regions differ. [Original PMID38049663](https://pubmed.ncbi.nlm.nih.gov/38049663/). Original Results0/2/7/14 confirm endogenous AID baseline controls, nascent versus stable-RNA differences, and cross-cell-state experiments. Provider's 96% figure concerns changed DHSs, not every DHS in the genome. Drug-treatment text and figure captions differ between 10 and 12 hours; no invented unified time is used. [Original PMID38811575](https://pubmed.ncbi.nlm.nih.gov/38811575/). Provider omitted this original. Actual Results0/1/5/6 verify rapid degron/inhibitor effects and nontoxic inhibitor controls, but the dTAG clone starts with approximately 50% SMARCA4 and altered baseline. Few strong early PRO-seq changes do not demonstrate immediate global transcription loss or refute later dependency. [Original PMID33558760](https://pubmed.ncbi.nlm.nih.gov/33558760/). Original abstract verifies roughly 101000 accessible regions and 30% containing an activator, silencer or both. Provider numbers are retained only as the reporter assay's result. The remaining 70% are not proved incompetent endogenous loci, and accessible silencers need not activate their own genomic transcription. [Original PMID35858748](https://pubmed.ncbi.nlm.nih.gov/35858748/). Original 2023 published abstract, rather than the provider 2022 label, reports genetically validated Zelda-dependent priming and additional patterning-factor activation. This supports separate tiers; computational fit alone does not prove state causality. [Original PMID37557175](https://pubmed.ncbi.nlm.nih.gov/37557175/). Consensus was used to identify literature and cross-check specific claims about design, endpoints, scope and research gaps. Those aspects were checked against original primary abstracts/status records and selected original Methods/Results passages. Consensus output was not treated as original full text. Provider search omissions are not evidence that a study does not exist. Source access and examination receipts are retained. Scite use or monthly unavailability is recorded per case; provider citation counts do not change causal grades. ## Research timeline and gaps: Chromatin Accessibility = Transcriptional Competence Selected publication milestones, not an exhaustive history or discovery priority claim. **2008 — Local upstream ncRNA transcription is required for fbp1 chromatin opening in fission yeast, demonstrating a reverse-direction route.** [Original PMID18820678](https://pubmed.ncbi.nlm.nih.gov/18820678/). **2015 — 2015:targeted p300 acetyltransferase activates endogenous genes; artificial acetylation/coactivator recruitment is separated from opening alone.** [Original PMID25849900](https://pubmed.ncbi.nlm.nih.gov/25849900/). **2017 — 2017:OCT4 requires BRG1 for selected regulatory-element function in mouse ESCs, mapping pioneer/remodeler cooperation.** [Original PMID28287392](https://pubmed.ncbi.nlm.nih.gov/28287392/). **2019 — 2019:repli-ATAC and transcription inhibition show transcription restart contributes to postreplication accessibility restoration.** [Original PMID31126739](https://pubmed.ncbi.nlm.nih.gov/31126739/). **2020 — 2020:early zebrafish opening precedes activation and largely survives transcription inhibition, with miR430 as an exception.** [Original PMID31940339](https://pubmed.ncbi.nlm.nih.gov/31940339/). **2021 — 2021:acute BAF degradation/ATPase inhibition identifies minute-scale accessibility maintenance; early transcription effects and tag baselines require separate interpretation.** [Original PMID33558760](https://pubmed.ncbi.nlm.nih.gov/33558760/). **2022 — 2022:targeted active/dead HAT contrasts show opening alone can fail to activate an endogenous target during ZGA.** [Original PMID35182480](https://pubmed.ncbi.nlm.nih.gov/35182480/). **2023 — 2023:EP400 compensation restores many promoter states/outputs; paused-polymerase/BAF work published 2024 (PMID38049663) strengthens bidirectional cooperation.** [Original PMID37922899](https://pubmed.ncbi.nlm.nih.gov/37922899/). **2025 — 2025:BRG1 dose manipulation shows enhancer sensitivity and buffered transcription, refining a simple one-to-one access model.** [Original PMID40846763](https://pubmed.ncbi.nlm.nih.gov/40846763/). **2026 — 2026:single-fiber nucleosome-distortion and factor-domain experiments refine the physical meaning of molecular DNA access.** [Original PMID42056506](https://pubmed.ncbi.nlm.nih.gov/42056506/). ## Research gaps A selective accessible-state necessity intervention must preserve the multifunctional regulators that establish it. Competence requires a standardized activating challenge and cannot be inferred from either basal ATAC or basal RNA alone. Bulk ATAC/DNase, methylase footprinting, local nucleosome distortion and large-scale decondensation measure different aspects of access. Temporal direction depends on developmental, replication and stimulus context; a universal upstream or downstream account fails. Specificity of factor/remodeler perturbations must exclude cell-cycle, viability, replication stress and transcriptional-collapse alternatives at each sampled time. Opening-only sufficiency fails at named loci, while acetylation/coactivator rescue can work; these need independent locus/state replication. Preprint/update duplication, shared reagents and repeated loci must be distinguished from independent error classes. ## Boundary experiment At prespecified native promoters/enhancers, alter DNA accessibility with an orthogonal state intervention while preserving factor occupancy, activation domains, acetylation/coactivators and polymerase function as far as possible. Apply a matched activating stimulus and measure initiation/bursting with calibrated nascent RNA and single-fiber accessibility. Restore only the accessible state in a matched rescue; retain a dead-HAT opening-without-activation control. Verify cell-cycle distribution, replication stress, viability, target-factor abundance and local cis sequence across developmental/replication windows. ## ADVERSARIAL REVIEW AND APPROVAL **Authoring model:** Sol 6.1. **Adversarial reviewer:** Claude Opus 5.5 (Anthropic). **Date:** 2026-10-14. **Scope of checks.** All 61 REFERENCES PMIDs verified against PubMed `get_article_metadata` (61/61 resolve to the stated title, first author, journal and year within the plus-or-minus-1 print/e-pub convention; no retractions or expressions of concern; the attached Update-of and Erratum-in PMIDs were left as recorded). Eleven load-bearing claims spot-checked against original abstracts, concentrating on the three that carry the level: the NPS/catalytic-dead-HAT asb11 result (PMID 35182480), the SWI/SNF-inhibition and EP400 compensation result (PMID 37922899), and the paused-RNAPII/BAF synergy result (PMID 38049663). Scoring logic checked: the six universal caps and cap precedence, the pre-registered aggregation rule and its reported alternatives, the recorded one-tier falsification downgrades for SC3 and SC4, the Beta/Gamma/Delta boundary, the Zeta independence basis, the confidence-band text, the role-of-mechanism derivation, the Momentum artifact requirement and the competing-model tournament fields. Validator re-run. | ID | Severity | Location | Original to corrected | Evidence | |---|---|---|---|---| | A1 | Editorial | Throughout review.md (57 replacements) | Rendering defects: missing spaces around numerals, acronyms and Greek letters, and malformed linked-notice strings - e.g. "PreliminaryΓ→Β", "mouseESCs", "targetedHAT", "approximately50%SMARCA4", "roughly101000accessible regions and30%containing", "between10and12hours", "UpdateOf: PMID36711459", "ErratumIn: PMID31348880" - corrected to spaced forms, "Update of: PMID 36711459" and "Erratum in: PMID 31348880" | Known reference-builder rendering defects. No numeral, percentage, locus name or PMID value altered; house-style PMID suffixes and the machine body-section receipts ("1:Results:paragraph14") were left untouched. | | A2 | Minor | scorecard.json `final_score.confidence_rationale` | "...density, heterogeneous controls and incomplete access set the confidence..." - restated on evidence density, multifunctional perturbations, reporter rather than endogenous readouts and heterogeneous timing/dose controls, with reviewer access explicitly excluded | `references/hsef-framework.md`, Confidence band: "Confidence reflects evidence density and reproducibility." Reviewer access depth is not a listed criterion. Applying the two-step test, the band stands at **Moderate**: the review documents substantive evidence-quality reservations of its own (mediator perturbations that change several functions at once, reporter and in-vitro readouts, drug-timing and viability windows), which are valid determinants, so the High text is not reached. | | A3 | Editorial | video-insert.md | "examined61primary reports", "from6original papers", "HSEFv5.3" - corrected to spaced forms | Same rendering-defect class as A1. | **Rejected findings (checked, no change).** 1. *"Best-supported rival" renderer bug.* Checked `competing_models.models_evaluated`: entry 0 is rank 1 with `is_nominal: false` (Polymerase-remodeler-factor cooperation), while the nominal is entry 4 at rank 5. The prose names the genuine rank-1 rival. No change. 2. *Scope-matched aggregation.* The declared rule is primary-subclaim (SC2), applied as written. The reported alternatives are correct: weakest-link Β is the lowest subclaim, and scope-matched Γ is right because all four subclaims carry the registered endogenous-locus scope and SC2 is the highest of them. The Ε-level entries are tournament models, not subclaims, and so cannot set the headline. No change. 3. *Falsification downgrades.* SC3 and SC4 are recorded as partial Γ downgraded one tier to Β against named triggered patterns (opening-without-activation at asb11 plus the EP400 cluster result for SC3; postreplication restart, polymerase/BAF pausing and upstream ncRNA transcription for SC4). This follows SKILL.md Step 11 ("For each triggered falsification pattern, downgrade one tier toward Α"). Arithmetic and direction both check out. Retained. 4. *Momentum.* "Mechanistic only" with four named ongoing mechanism programmes (PMIDs 40846763, 42056506, 40252649, 41135527) and an explicit statement that none supplies the selective necessity experiment. Not boilerplate, and correctly avoids "Decisive work underway" for completed publications. 5. *The asb11 catalytic-dead-HAT claim.* Not in the PubMed abstract for PMID 35182480, which records only that NPS function in activation "can be bypassed by recruiting histone acetyltransferase to individual genes". The review attributes the dead-HAT control to named original Results panels at its recorded body-examination depth and flags that targeted HAT also changes acetylation and cofactor recruitment. The claim is consistent with the abstract's direction and is correctly hedged, so it is retained with the review's own access caveat rather than treated as a misattribution. 6. *Headline level.* Γ was argued both up to Δ (acute BAF/BRG1 degron perturbations are endogenous in vivo and do change nascent transcription) and down to Β, and both were rejected: the Δ-candidate perturbations act on mediators rather than on the measured accessible state, which is what the registered claim is about, while Β understates genuine partial system support. Retained. 7. *Collective-author and empty-DOI defects.* None present. 8. *Provenance clauses.* No false-approval boilerplate and no false provenance clause; the REVIEWER NOTES correctly record that Consensus browser synthesis was used for this case, which matches the Consensus reconciliation section. No earlier adversarial approval is asserted, and none was invented. 9. *Counts.* 61 sources / 66 claims / 66 verified / 0 unverified agree between the banner, scorecard `provenance_header` and `verification_summary`. **Residual limitations.** Verification remains bounded attribution: 55 of 61 sources were examined at abstract/status depth only, so the figure-level controls that carry the SC3 downgrade rest on the review's own body-examination receipts rather than on an independent full-text audit by this pass. No literature search was re-run, so completeness at the 2026-10-09 cutoff is not certified. **Approval:** Following adversarial review and the corrections listed above, the revised document is approved. - Claude Opus 5.5 (Anthropic), 2026-10-14. ## REFERENCES 1. Ren G, Ku WL, Ge G et al. Acute depletion of BRG1 reveals its primary function as an activator of transcription. Nature communications. 2024. [PMID 38811575](https://pubmed.ncbi.nlm.nih.gov/38811575/). DOI: 10.1038/s41467-024-48911-z. Access: full_text_partial. Study: PMID38811575. 2. Blümli S, Wiechens N, Wu MY et al. Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription. Cell reports. 2021. [PMID 34731603](https://pubmed.ncbi.nlm.nih.gov/34731603/). DOI: 10.1016/j.celrep.2021.109943. Access: abstract_metadata. Study: PMID34731603. 3. Schick S, Grosche S, Kohl KE et al. Acute BAF perturbation causes immediate changes in chromatin accessibility. Nature genetics. 2021. [PMID 33558760](https://pubmed.ncbi.nlm.nih.gov/33558760/). DOI: 10.1038/s41588-021-00777-3. Access: full_text_partial. Study: PMID33558760. 4. Brahma S, Henikoff S. The BAF chromatin remodeler synergizes with RNA polymerase II and transcription factors to evict nucleosomes. Nature genetics. 2024. [PMID 38049663](https://pubmed.ncbi.nlm.nih.gov/38049663/). DOI: 10.1038/s41588-023-01603-8. Access: full_text_partial. Study: BAF_RNAPII_COOPERATION_PUBLISHED. 5. Martin BJE, Ablondi EF, Goglia C et al. Global identification of SWI/SNF targets reveals compensation by EP400. Cell. 2023. [PMID 37922899](https://pubmed.ncbi.nlm.nih.gov/37922899/). DOI: 10.1016/j.cell.2023.10.006. Access: full_text_partial. Study: PMID37922899. 6. Hagihara Y, Zhang C, Zhang Y. Precise modulation of BRG1 levels reveals features of mSWI/SNF dosage sensitivity. Nature genetics. 2025. [PMID 40846763](https://pubmed.ncbi.nlm.nih.gov/40846763/). DOI: 10.1038/s41588-025-02305-z. Access: abstract_metadata. Study: PMID40846763. 7. Narita T, Ito S, Higashijima Y et al. Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release. Molecular cell. 2021. [PMID 33765415](https://pubmed.ncbi.nlm.nih.gov/33765415/). DOI: 10.1016/j.molcel.2021.03.008. Access: abstract_metadata. Study: PMID33765415. 8. King HW, Klose RJ. The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells. eLife. 2017. [PMID 28287392](https://pubmed.ncbi.nlm.nih.gov/28287392/). DOI: 10.7554/eLife.22631. Access: abstract_metadata. Study: PMID28287392. 9. Pálfy M, Schulze G, Valen E et al. Chromatin accessibility established by Pou5f3, Sox19b and Nanog primes genes for activity during zebrafish genome activation. PLoS genetics. 2020. [PMID 31940339](https://pubmed.ncbi.nlm.nih.gov/31940339/). DOI: 10.1371/journal.pgen.1008546. Access: full_text_partial. Study: ZEBRAFISH_NPS_PRIMING_2020. 10. Miao L, Tang Y, Bonneau AR et al. The landscape of pioneer factor activity reveals the mechanisms of chromatin reprogramming and genome activation. Molecular cell. 2022. [PMID 35182480](https://pubmed.ncbi.nlm.nih.gov/35182480/). DOI: 10.1016/j.molcel.2022.01.024. Access: full_text_partial. Study: ZEBRAFISH_NPS_TARGETED_RESCUE_2022. 11. Stewart-Morgan KR, Reverón-Gómez N, Groth A. Transcription Restart Establishes Chromatin Accessibility after DNA Replication. Molecular cell. 2019. [PMID 31126739](https://pubmed.ncbi.nlm.nih.gov/31126739/). DOI: 10.1016/j.molcel.2019.04.033. Access: abstract_metadata. Study: PMID31126739. 12. Tullius TW, Isaac RS, Dubocanin D et al. RNA polymerases reshape chromatin architecture and couple transcription on individual fibers. Molecular cell. 2024. [PMID 39191261](https://pubmed.ncbi.nlm.nih.gov/39191261/). DOI: 10.1016/j.molcel.2024.08.013. Access: abstract_metadata. Study: DROSOPHILA_FIBERSEQ_PUBLISHED. 13. MacCarthy CM, Huertas J, Ortmeier C et al. OCT4 interprets and enhances nucleosome flexibility. Nucleic acids research. 2022. [PMID 36130732](https://pubmed.ncbi.nlm.nih.gov/36130732/). DOI: 10.1093/nar/gkac755. Access: abstract_metadata. Study: PMID36130732. 14. Huertas J, MacCarthy CM, Schöler HR et al. Nucleosomal DNA Dynamics Mediate Oct4 Pioneer Factor Binding. Biophysical journal. 2020. [PMID 32027821](https://pubmed.ncbi.nlm.nih.gov/32027821/). DOI: 10.1016/j.bpj.2019.12.038. Access: abstract_metadata. Study: PMID32027821. 15. Johnson TA, Chereji RV, Stavreva DA et al. Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo. Nucleic acids research. 2018. [PMID 29126175](https://pubmed.ncbi.nlm.nih.gov/29126175/). DOI: 10.1093/nar/gkx1044. Access: abstract_metadata. Study: PMID29126175. 16. Li T, Liu Q, Chen Z et al. Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model. Nature communications. 2022. [PMID 35672415](https://pubmed.ncbi.nlm.nih.gov/35672415/). DOI: 10.1038/s41467-022-30960-x. Access: abstract_metadata. Study: PMID35672415. 17. Takaku M, Grimm SA, Shimbo T et al. GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler. Genome biology. 2016. [PMID 26922637](https://pubmed.ncbi.nlm.nih.gov/26922637/). DOI: 10.1186/s13059-016-0897-0. Access: abstract_metadata. Study: PMID26922637. 18. Meers MP, Janssens DH, Henikoff S. Pioneer Factor-Nucleosome Binding Events during Differentiation Are Motif Encoded. Molecular cell. 2019. [PMID 31253573](https://pubmed.ncbi.nlm.nih.gov/31253573/). DOI: 10.1016/j.molcel.2019.05.025. Access: abstract_metadata. Study: PMID31253573. 19. Liu Z, Kraus WL. Catalytic-Independent Functions of PARP-1 Determine Sox2 Pioneer Activity at Intractable Genomic Loci. Molecular cell. 2017. [PMID 28212747](https://pubmed.ncbi.nlm.nih.gov/28212747/). DOI: 10.1016/j.molcel.2017.01.017. Access: abstract_metadata. Study: PMID28212747. 20. Hansen JL, Loell KJ, Cohen BA. A test of the pioneer factor hypothesis using ectopic liver gene activation. eLife. 2022. [PMID 34984978](https://pubmed.ncbi.nlm.nih.gov/34984978/). DOI: 10.7554/eLife.73358. Access: abstract_metadata. Study: PMID34984978. 21. Adachi K, Kopp W, Wu G et al. Esrrb Unlocks Silenced Enhancers for Reprogramming to Naive Pluripotency. Cell stem cell. 2018. [PMID 29910149](https://pubmed.ncbi.nlm.nih.gov/29910149/). DOI: 10.1016/j.stem.2018.05.020. Access: abstract_metadata. Study: PMID29910149. 22. Yu X, Singh PK, Tabrejee S et al. ΔNp63 is a pioneer factor that binds inaccessible chromatin and elicits chromatin remodeling. Epigenetics & chromatin. 2021. [PMID 33865440](https://pubmed.ncbi.nlm.nih.gov/33865440/). DOI: 10.1186/s13072-021-00394-8. Access: abstract_metadata. Study: PMID33865440. 23. Orlando KA, Grimm SA, Wade PA. Pioneering new enhancers by GATA3: role of facilitating transcription factors and chromatin remodeling. Nucleic acids research. 2025. [PMID 40479714](https://pubmed.ncbi.nlm.nih.gov/40479714/). DOI: 10.1093/nar/gkaf473. Access: abstract_metadata. Study: PMID40479714. 24. Eck E, Liu J, Kazemzadeh-Atoufi M et al. Quantitative dissection of transcription in development yields evidence for transcription-factor-driven chromatin accessibility. eLife. 2020. [PMID 33074101](https://pubmed.ncbi.nlm.nih.gov/33074101/). DOI: 10.7554/eLife.56429. Access: abstract_metadata. Study: PMID33074101. 25. Yang MG, Richter HJ, Wang S et al. Pervasive and programmed nucleosome distortion on single chromatin fibres. Nature. 2026. [PMID 42056506](https://pubmed.ncbi.nlm.nih.gov/42056506/). DOI: 10.1038/s41586-026-10418-6. Access: abstract_metadata. Study: IDLI_NUCLEOSOME_DISTORTION_PUBLISHED. 26. Shen J, Varshney D, Simeone A et al. Promoter G-quadruplex folding precedes transcription and is controlled by chromatin. Genome biology. 2021. [PMID 33962653](https://pubmed.ncbi.nlm.nih.gov/33962653/). DOI: 10.1186/s13059-021-02346-7. Access: abstract_metadata. Study: PMID33962653. 27. Jiang Y, Huang J, Lun K et al. Genome-wide analyses of chromatin interactions after the loss of Pol I, Pol II, and Pol III. Genome biology. 2020. [PMID 32616013](https://pubmed.ncbi.nlm.nih.gov/32616013/). DOI: 10.1186/s13059-020-02067-3. Access: abstract_metadata. Study: PMID32616013. 28. Bulut-Karslioglu A, Macrae TA, Oses-Prieto JA et al. The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output. Cell stem cell. 2018. [PMID 29499153](https://pubmed.ncbi.nlm.nih.gov/29499153/). DOI: 10.1016/j.stem.2018.02.004. Access: abstract_metadata. Study: PMID29499153. 29. Pincus D, Anandhakumar J, Thiru P et al. Genetic and epigenetic determinants establish a continuum of Hsf1 occupancy and activity across the yeast genome. Molecular biology of the cell. 2018. [PMID 30332327](https://pubmed.ncbi.nlm.nih.gov/30332327/). DOI: 10.1091/mbc.E18-06-0353. Access: abstract_metadata. Study: PMID30332327. 30. Corces MR, Granja JM, Shams S et al. The chromatin accessibility landscape of primary human cancers. Science (New York, N.Y.). 2018. [PMID 30361341](https://pubmed.ncbi.nlm.nih.gov/30361341/). DOI: 10.1126/science.aav1898. Access: abstract_metadata. Study: PMID30361341. 31. Cusanovich DA, Hill AJ, Aghamirzaie D et al. A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility. Cell. 2018. [PMID 30078704](https://pubmed.ncbi.nlm.nih.gov/30078704/). DOI: 10.1016/j.cell.2018.06.052. Access: abstract_metadata. Study: PMID30078704. 32. Buenrostro JD, Wu B, Litzenburger UM et al. Single-cell chromatin accessibility reveals principles of regulatory variation. Nature. 2015. [PMID 26083756](https://pubmed.ncbi.nlm.nih.gov/26083756/). DOI: 10.1038/nature14590. Access: abstract_metadata. Study: PMID26083756. 33. Domcke S, Hill AJ, Daza RM et al. A human cell atlas of fetal chromatin accessibility. Science (New York, N.Y.). 2020. [PMID 33184180](https://pubmed.ncbi.nlm.nih.gov/33184180/). DOI: 10.1126/science.aba7612. Access: abstract_metadata. Study: PMID33184180. 34. Yan RE, Corman A, Katgara L et al. Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling. Nature biotechnology. 2025. [PMID 39572737](https://pubmed.ncbi.nlm.nih.gov/39572737/). DOI: 10.1038/s41587-024-02475-x. Access: abstract_metadata. Study: PMID39572737. 35. Farmer A, Thibivilliers S, Ryu KH et al. Single-nucleus RNA and ATAC sequencing reveals the impact of chromatin accessibility on gene expression in Arabidopsis roots at the single-cell level. Molecular plant. 2021. [PMID 33422696](https://pubmed.ncbi.nlm.nih.gov/33422696/). DOI: 10.1016/j.molp.2021.01.001. Access: abstract_metadata. Study: PMID33422696. 36. Xu J, Huang Y, Han Z et al. METTL3 uncouples chromatin accessibility from transcription during retinal development. Stem cell reports. 2025. [PMID 41135527](https://pubmed.ncbi.nlm.nih.gov/41135527/). DOI: 10.1016/j.stemcr.2025.102690. Access: abstract_metadata. Study: PMID41135527. 37. Murphy KE, Meng FW, Makowski CE et al. Genome-wide chromatin accessibility is restricted by ANP32E. Nature communications. 2020. [PMID 33033242](https://pubmed.ncbi.nlm.nih.gov/33033242/). DOI: 10.1038/s41467-020-18821-x. Access: abstract_metadata. Study: PMID33033242. 38. Liscovitch-Brauer N, Montalbano A, Deng J et al. Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens. Nature biotechnology. 2021. [PMID 33927415](https://pubmed.ncbi.nlm.nih.gov/33927415/). DOI: 10.1038/s41587-021-00902-x. Access: abstract_metadata. Study: PMID33927415. 39. Currin KW, Erdos MR, Narisu N et al. Genetic effects on liver chromatin accessibility identify disease regulatory variants. American journal of human genetics. 2021. [PMID 34038741](https://pubmed.ncbi.nlm.nih.gov/34038741/). DOI: 10.1016/j.ajhg.2021.05.001. Access: abstract_metadata. Study: PMID34038741. 40. Desanlis I, Kherdjemil Y, Mayran A et al. HOX13-dependent chromatin accessibility underlies the transition towards the digit development program. Nature communications. 2020. [PMID 32427842](https://pubmed.ncbi.nlm.nih.gov/32427842/). DOI: 10.1038/s41467-020-16317-2. Access: abstract_metadata. Study: PMID32427842. 41. Yang Y, Gomez N, Infarinato N et al. The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates. Nature cell biology. 2023. [PMID 37488435](https://pubmed.ncbi.nlm.nih.gov/37488435/). DOI: 10.1038/s41556-023-01184-y. Access: abstract_metadata. Study: PMID37488435. 42. Gong W, Das S, Sierra-Pagan JE et al. ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage. Nature cell biology. 2022. [PMID 35550615](https://pubmed.ncbi.nlm.nih.gov/35550615/). DOI: 10.1038/s41556-022-00901-3. Access: abstract_metadata. Study: PMID35550615. 43. Pelletier A, Mayran A, Gouhier A et al. Pax7 pioneer factor action requires both paired and homeo DNA binding domains. Nucleic acids research. 2021. [PMID 34197620](https://pubmed.ncbi.nlm.nih.gov/34197620/). DOI: 10.1093/nar/gkab561. Access: abstract_metadata. Study: PMID34197620. 44. Cho CY, O'Farrell PH. Stepwise modifications of transcriptional hubs link pioneer factor activity to a burst of transcription. Nature communications. 2023. [PMID 37563108](https://pubmed.ncbi.nlm.nih.gov/37563108/). DOI: 10.1038/s41467-023-40485-6. Access: abstract_metadata. Study: PMID37563108. 45. Hu Y, Kireev I, Plutz M et al. Large-scale chromatin structure of inducible genes: transcription on a condensed, linear template. The Journal of cell biology. 2009. [PMID 19349581](https://pubmed.ncbi.nlm.nih.gov/19349581/). DOI: 10.1083/jcb.200809196. Access: abstract_metadata. Study: PMID19349581. 46. Tajik A, Zhang Y, Wei F et al. Transcription upregulation via force-induced direct stretching of chromatin. Nature materials. 2016. [PMID 27548707](https://pubmed.ncbi.nlm.nih.gov/27548707/). DOI: 10.1038/nmat4729. Access: abstract_metadata. Study: PMID27548707. 47. Hirota K, Miyoshi T, Kugou K et al. Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs. Nature. 2008. [PMID 18820678](https://pubmed.ncbi.nlm.nih.gov/18820678/). DOI: 10.1038/nature07348. Access: abstract_metadata. Study: PMID18820678. 48. Yan C, Chen H, Bai L. Systematic Study of Nucleosome-Displacing Factors in Budding Yeast. Molecular cell. 2018. [PMID 30017582](https://pubmed.ncbi.nlm.nih.gov/30017582/). DOI: 10.1016/j.molcel.2018.06.017. Access: abstract_metadata. Study: PMID30017582. 49. Grand RS, Pregnolato M, Baumgartner L et al. Genome access is transcription factor-specific and defined by nucleosome position. Molecular cell. 2024. [PMID 39208807](https://pubmed.ncbi.nlm.nih.gov/39208807/). DOI: 10.1016/j.molcel.2024.08.009. Access: abstract_metadata. Study: PMID39208807. 50. Liao J, Ho J, Burns M et al. Collaboration between distinct SWI/SNF chromatin remodeling complexes directs enhancer selection and activation of macrophage inflammatory genes. Immunity. 2024. [PMID 38843835](https://pubmed.ncbi.nlm.nih.gov/38843835/). DOI: 10.1016/j.immuni.2024.05.008. Access: abstract_metadata. Study: PMID38843835. 51. Grossi E, Nguyen CB, Carcamo S et al. The SWI/SNF PBAF complex facilitates REST occupancy at repressive chromatin. Molecular cell. 2025. [PMID 40252649](https://pubmed.ncbi.nlm.nih.gov/40252649/). DOI: 10.1016/j.molcel.2025.03.026. Access: abstract_metadata. Study: PMID40252649. 52. Mivelaz M, Cao AM, Kubik S et al. Chromatin Fiber Invasion and Nucleosome Displacement by the Rap1 Transcription Factor. Molecular cell. 2020. [PMID 31761495](https://pubmed.ncbi.nlm.nih.gov/31761495/). DOI: 10.1016/j.molcel.2019.10.025. Access: abstract_metadata. Study: PMID31761495. 53. Menet JS, Pescatore S, Rosbash M. CLOCK:BMAL1 is a pioneer-like transcription factor. Genes & development. 2014. [PMID 24395244](https://pubmed.ncbi.nlm.nih.gov/24395244/). DOI: 10.1101/gad.228536.113. Access: abstract_metadata. Study: PMID24395244. 54. Minderjahn J, Schmidt A, Fuchs A et al. Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1. Nature communications. 2020. [PMID 31964861](https://pubmed.ncbi.nlm.nih.gov/31964861/). DOI: 10.1038/s41467-019-13960-2. Access: abstract_metadata. Study: PMID31964861. 55. Cabal-Hierro L, van Galen P, Prado MA et al. Chromatin accessibility promotes hematopoietic and leukemia stem cell activity. Nature communications. 2020. [PMID 32179749](https://pubmed.ncbi.nlm.nih.gov/32179749/). DOI: 10.1038/s41467-020-15221-z. Access: abstract_metadata. Study: PMID32179749. 56. Helminen L, Huttunen J, Tulonen M et al. Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer. Nucleic acids research. 2024. [PMID 38015476](https://pubmed.ncbi.nlm.nih.gov/38015476/). DOI: 10.1093/nar/gkad1126. Access: abstract_metadata. Study: PMID38015476. 57. Hilton IB, D'Ippolito AM, Vockley CM et al. Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. Nature biotechnology. 2015. [PMID 25849900](https://pubmed.ncbi.nlm.nih.gov/25849900/). DOI: 10.1038/nbt.3199. Access: abstract_metadata. Study: PMID25849900. 58. Dominguez AA, Chavez MG, Urke A et al. CRISPR-Mediated Synergistic Epigenetic and Transcriptional Control. The CRISPR journal. 2022. [PMID 35271371](https://pubmed.ncbi.nlm.nih.gov/35271371/). DOI: 10.1089/crispr.2021.0099. Access: abstract_metadata. Study: PMID35271371. 59. Saha D, Animireddy S, Lee J et al. Enhancer switching in cell lineage priming is linked to eRNA, Brg1's AT-hook, and SWI/SNF recruitment. Molecular cell. 2024. [PMID 38593804](https://pubmed.ncbi.nlm.nih.gov/38593804/). DOI: 10.1016/j.molcel.2024.03.013. Access: abstract_metadata. Study: PMID38593804. 60. Hansen TJ, Hodges E. ATAC-STARR-seq reveals transcription factor-bound activators and silencers within chromatin-accessible regions of the human genome. Genome research. 2022. [PMID 35858748](https://pubmed.ncbi.nlm.nih.gov/35858748/). DOI: 10.1101/gr.276766.122. Access: abstract_metadata. Study: PMID35858748. 61. Brennan KJ, Weilert M, Krueger S et al. Chromatin accessibility in the Drosophila embryo is determined by transcription factor pioneering and enhancer activation. Developmental cell. 2023. [PMID 37557175](https://pubmed.ncbi.nlm.nih.gov/37557175/). DOI: 10.1016/j.devcel.2023.07.007. Access: abstract_metadata. Study: PMID37557175. ## Source-specific evidence cards ### [1] Acute depletion of BRG1 reveals its primary function as an activator of transcription. **Shows:** Endogenous BRG1-AID depletion reduces nascent RNA, RNAPII occupancy and DHS accessibility in primary mouse cells without measured viability/growth defects. **Does not show:** BRG1 loss also changes nucleosomes, p300 and acetylation; it does not selectively remove accessible state while preserving other mediator functions. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:Results:paragraph0, 1:Results:paragraph2, 1:Results:paragraph7, 1:Results:paragraph14. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [2] Acute depletion of the ARID1A subunit of SWI/SNF complexes reveals distinct pathways for activation and repression of transcription. **Shows:** Acute ARID1A degron causes rapid accessibility/EP300 changes but comparatively few early differentially expressed genes; later adaptive transcript changes dominate. **Does not show:** EP300 redistribution and multifactor effects prevent accessibility-specific necessity; steady-state RNA and timing affect apparent coupling. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [3] Acute BAF perturbation causes immediate changes in chromatin accessibility. **Shows:** dTAG, ATPase inhibition and degradation rapidly alter BAF-dependent accessibility with smaller early PRO-seq changes under nontoxic inhibitor conditions. **Does not show:** dTAG clone begins with about 50% SMARCA4 and baseline changes; rapid accessibility loss is not a selectively isolated state perturbation or immediate global loss of transcription. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 0:Results:paragraph0, 0:Results:paragraph1, 0:Results:paragraph5, 0:Results:paragraph6. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [4] The BAF chromatin remodeler synergizes with RNA polymerase II and transcription factors to evict nucleosomes. **Shows:** Chemical-genetic time courses show paused RNAPII stabilizes BAF occupancy and ATPase-dependent eviction; TF binding confers locus specificity. **Does not show:** Inhibition changes transcription machinery directly; ≤2 h triptolide viability controls do not extend to 4 h, and bidirectional synergy is not universal upstream opening. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:Results:paragraph2, 1:Results:paragraph3, 1:Results:paragraph9, 1:Results:paragraph14. No complete-paper or supplement audit claimed. Update of: PMID 36711459. Subclaims: SC1, SC2, SC4. ### [5] Global identification of SWI/SNF targets reveals compensation by EP400. **Shows:** Fast SWISNF inhibition reduces accessibility/transcription; EP400 restores promoter accessibility and expression during prolonged inhibition, with no toxicity in early windows. **Does not show:** Above-control ATAC recovery need not increase transcription above control; factor activity and state remain coupled despite orthogonal inhibitor/degrader/EP400 tests. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:RESULTS:paragraph1, 1:RESULTS:paragraph2, 1:RESULTS:paragraph6, 1:RESULTS:paragraph8, 1:RESULTS:paragraph25, 1:RESULTS:paragraph26. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC3, SC4. ### [6] Precise modulation of BRG1 levels reveals features of mSWI/SNF dosage sensitivity. **Shows:** Dose-graded BRG1 degradation reveals enhancer-specific accessibility and buffered transcription with promoters/insulators often unaffected. **Does not show:** Protein dosage tests multifunctional remodeler, not accessible state alone; nonlinear buffering defeats one-to-one competence inference. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [7] Enhancers are activated by p300/CBP activity-dependent PIC assembly, RNAPII recruitment, and pause release. **Shows:** p300/CBP catalytic activity controls rapid PIC/RNAPII recruitment and pause release while TF/coactivator recruitment persists. **Does not show:** This isolates acetylation-dependent activation, not accessibility-only necessity; original body was not publicly retrieved in this audit. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [8] The pioneer factor OCT4 requires the chromatin remodeller BRG1 to support gene regulatory element function in mouse embryonic stem cells. **Shows:** OCT4 loss and BRG1 requirement constrain endogenous mouse ESC binding, accessibility and pluripotency transcription. **Does not show:** Factor/remodeler functions and cell-state regulation are not independent accessible-state manipulation. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [9] Chromatin accessibility established by Pou5f3, Sox19b and Nanog primes genes for activity during zebrafish genome activation. **Shows:** Zebrafish regulatory opening precedes transcription and persists under alpha-amanitin except miR430; maternal-factor loss reduces opening. **Does not show:** Priming is not sufficient activation; transcription independence in this window is not universal across replication/cell states, and nearest-neighbor enhancer links are inferred. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:Results:paragraph2, 1:Results:paragraph4, 1:Results:paragraph7, 1:Results:paragraph12. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3, SC4. ### [10] The landscape of pioneer factor activity reveals the mechanisms of chromatin reprogramming and genome activation. **Shows:** NPS-null zebrafish have lost enhancer opening; locus dCas9 active HAT restores transcription, while catalytic-dead HAT restores opening without transcription at asb11. **Does not show:** Clean opening-without-activation discriminates sufficiency but does not prove a universal necessity of measured ATAC; targeted HAT also changes acetylation/cofactor recruitment. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. Selected body sections: 1:Results:paragraph1, 1:Results:paragraph7, 1:Results:paragraph8. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [11] Transcription Restart Establishes Chromatin Accessibility after DNA Replication. **Shows:** Postreplication transcription restart is required to restore active chromatin accessibility in mouse ESCs by repli-ATAC and transcription inhibition. **Does not show:** Replication-conditioned restoration is not every locus/state; linked erratum PMID31348880 was identified but its details were not read. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. Erratum in: PMID 31348880. Subclaims: SC2, SC4. ### [12] RNA polymerases reshape chromatin architecture and couple transcription on individual fibers. **Shows:** Fiber-seq resolves polymerase/nucleosome footprints and pausing-dependent nucleosome destabilization/coupling on individual Drosophila fibers. **Does not show:** Single-fiber structure and perturbation address transcription-to-chromatin feedback, not opening as an independent universal competence determinant. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. Update of: PMID 38187631. Subclaims: SC1, SC2, SC4. ### [13] OCT4 interprets and enhances nucleosome flexibility. **Shows:** Experiments/simulations show OCT4 stabilizes flexible/open nucleosome conformations depending on motif position and histone tails. **Does not show:** Structural binding does not establish endogenous transcript necessity or sufficiency. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [14] Nucleosomal DNA Dynamics Mediate Oct4 Pioneer Factor Binding. **Shows:** Molecular simulations predict nucleosome breathing/twisting and partial-motif recognition permit OCT4 binding. **Does not show:** Computation is original research but no functional causal transcription crossing or direct endogenous measurement. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [15] Conventional and pioneer modes of glucocorticoid receptor interaction with enhancer chromatin in vivo. **Shows:** Hormone-induced GR binds both preaccessible and nucleosomal/inaccessible enhancer classes and recruits BRG1 with shifts. **Does not show:** GR/BRG1 perturbation and hormone exposure do not isolate accessibility state; nucleosomal and DNase sensitivity are not interchangeable. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [16] Dynamic nucleosome landscape elicits a noncanonical GATA2 pioneer model. **Shows:** Androgen time courses support GATA2 binding at inaccessible nucleosome edges before remodeling and downstream regulation. **Does not show:** Multifactor binding/state changes do not establish opening-only competence or generalize from LNCaPcells. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [17] GATA3-dependent cellular reprogramming requires activation-domain dependent recruitment of a chromatin remodeler. **Shows:** GATA3 activation-domain deletion retains binding but prevents productive remodeling/MET; some bound loci slide nucleosomes without becoming accessible. **Does not show:** Ectopic reprogramming and lost recruitment functions do not establish endogenous accessible-state necessity. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [18] Pioneer Factor-Nucleosome Binding Events during Differentiation Are Motif Encoded. **Shows:** Human ESC differentiation profiles show motif/context-dependent TF nucleosome binding, including at accessible loci. **Does not show:** Computational occupancy classification and time course do not selectively test necessity or sufficiency. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [19] Catalytic-Independent Functions of PARP-1 Determine Sox2 Pioneer Activity at Intractable Genomic Loci. **Shows:** PARP1 cooperates with Sox2 nucleosome binding independently of catalytic activity at selected native ESC loci. **Does not show:** Specific protein cooperation supports pioneer access but does not isolate opening from Sox2/cofactor regulation. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [20] A test of the pioneer factor hypothesis using ectopic liver gene activation. **Shows:** Ectopic FOXA1 and HNF4A each bind/open sites and activate genes, without a general sequential pioneer/nonpioneer distinction. **Does not show:** Overexpression is capped for endogenous function; demonstrates TF/context dependence rather than opening-alone sufficiency. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [21] Esrrb Unlocks Silenced Enhancers for Reprogramming to Naive Pluripotency. **Shows:** Esrrb binds silenced enhancers and recruits core factors with demethylation/p300/nucleosome changes during reprogramming. **Does not show:** Ectopic reprogramming and LIF/cofactor dependence constrain endogenous generalization; linked erratum PMID30526884 details unexamined. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. Erratum in: PMID 30526884. Subclaims: SC2, SC3, SC4. ### [22] ΔNp63 is a pioneer factor that binds inaccessible chromatin and elicits chromatin remodeling. **Shows:** Ectopic deltaNp63 binds inaccessible/unmodified nucleosome edges and induces acetylation/repositioning. **Does not show:** Engineered expression and nucleosome assays do not establish endogenous state necessity or universal activation. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [23] Pioneering new enhancers by GATA3: role of facilitating transcription factors and chromatin remodeling. **Shows:** Induced GATA3 productive/unproductive sites differ in cooperating factors; SWISNF ATPase inhibition removes induced accessibility/binding. **Does not show:** Ectopic TF, remodeler functions and context dependence prevent an opening-only claim. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [24] Quantitative dissection of transcription in development yields evidence for transcription-factor-driven chromatin accessibility. **Shows:** Live Drosophila transcription dynamics reject tested thermodynamic/MWC accessibility models and fit factor-catalyzed models better. **Does not show:** Predictive model fit is not a direct selective measurement or necessity test of the accessible state. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [25] Pervasive and programmed nucleosome distortion on single chromatin fibres. **Shows:** Single-fiber footprinting and TF-domain/genetic contrasts show regulated nucleosome distortion across mouse/human differentiation contexts. **Does not show:** TF-domain perturbation affects more than accessibility; distorted nucleosomes are not equivalent to bulk nucleosome-free ATAC peaks or direct activation. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. Update of: PMID 39896524. Subclaims: SC1, SC2, SC4. ### [26] Promoter G-quadruplex folding precedes transcription and is controlled by chromatin. **Shows:** G4 formation persists under initiation/elongation inhibition; compaction removes promoter G4/PolII and the G4 ligand partly preserves PolII. **Does not show:** Compaction/ligand have multiple effects and do not isolate accessibility from G4/protein recruitment; no universal direction. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [27] Genome-wide analyses of chromatin interactions after the loss of Pol I, Pol II, and Pol III. **Shows:** Polymerase degrons have modest early 3D effects but longer PolII loss changes accessibility/cohesin. **Does not show:** Time-dependent indirect effects and architecture/transcription/readout differences constrain direction claims. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [28] The Transcriptionally Permissive Chromatin State of Embryonic Stem Cells Is Acutely Tuned to Translational Output. **Shows:** Translation inhibition rapidly changes unstable euchromatin regulators, RNAPII and accessibility in ESCs/blastocysts. **Does not show:** Global translation/growth stress is not accessibility-specific perturbation and can explain multiple endpoints. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [29] Genetic and epigenetic determinants establish a continuum of Hsf1 occupancy and activity across the yeast genome. **Shows:** Hsf1 nuclear depletion/nascent RNA reveal factor-dependent transcription; heat-shock binding/disassembly differs across nucleosomal contexts. **Does not show:** Heat stress and RSC/factor interactions do not isolate accessibility-only necessity; basal and induced contexts differ. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [30] The chromatin accessibility landscape of primary human cancers. **Shows:** Primary human-cancer ATAC and multiomics reveal tissue/subtype-specific regulatory elements and expression links. **Does not show:** Bulk cell mixtures and inferred enhancers/links are observational, not competence necessity. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1. ### [31] A Single-Cell Atlas of In Vivo Mammalian Chromatin Accessibility. **Shows:** Single-cell mouse tissue accessibility atlas maps cell-type regulatory patterns and inferred expression relationships. **Does not show:** Atlas co-variation and crossmodal mapping do not selectively test causality. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1. ### [32] Single-cell chromatin accessibility reveals principles of regulatory variation. **Shows:** Single-cell ATAC reveals regulatory variability associated with factors and stimulus/cell-cycle perturbations. **Does not show:** Accessibility variability is not a direct transcript competence assay; signaling/cell cycle can confound coupling. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1. ### [33] A human cell atlas of fetal chromatin accessibility. **Shows:** Human fetal gene-expression/accessibility atlases map cell-type-specific candidate regulatory elements. **Does not show:** Atlas integration and motif/heritability enrichment are not selective causal dependency. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1. ### [34] Pooled CRISPR screens with joint single-nucleus chromatin accessibility and transcriptome profiling. **Shows:** Joint perturbation-accessibility-transcript profiling identifies differentiation regulators and ZNHIT1 in pediatric cancer. **Does not show:** Gene knockout perturbs multifunctional regulators; shared-cell modalities do not themselves isolate state mediation. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [35] Single-nucleus RNA and ATAC sequencing reveals the impact of chromatin accessibility on gene expression in Arabidopsis roots at the single-cell level. **Shows:** Integrated Arabidopsis root nucleus RNA/ATAC maps cell-type marker/accessibility patterns. **Does not show:** Species-specific atlas associations support correlation, not causal necessity or sufficiency. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1. ### [36] METTL3 uncouples chromatin accessibility from transcription during retinal development. **Shows:** METTL3 loss/degron and RNA editing reveal retinal transcription regulation with direct chromatin targets showing weak accessibility-output correlation. **Does not show:** RNA stability/m6A are alternative mediators; uncoupling does not prove no locus ever depends on accessibility. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. Update of: PMID 41256642. Subclaims: SC1, SC2, SC4. ### [37] Genome-wide chromatin accessibility is restricted by ANP32E. **Shows:** ANP32E loss changes H2AZ positioning, accessibility, TF binding and neighboring expression in fibroblasts. **Does not show:** Histone-variant/remodeler functions and broad perturbation do not isolate accessible state from other regulatory inputs. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [38] Profiling the genetic determinants of chromatin accessibility with scalable single-cell CRISPR screens. **Shows:** CRISPR-sciATAC perturbations map remodeler-specific accessibility, with EZH2 loss/HOX expression examples. **Does not show:** Chronic gene knockouts and state changes are not accessibility-only endogenous necessity tests. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [39] Genetic effects on liver chromatin accessibility identify disease regulatory variants. **Shows:** Human liver caQTLs identify allele-associated accessibility and aLITAFvariant has allele-specific binding/transcription activity. **Does not show:** Small tissue cohort, inferred gene links and altered TF sequence confound accessibility mediation; not a pure state instrument. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [40] HOX13-dependent chromatin accessibility underlies the transition towards the digit development program. **Shows:** HOX13 function is required for distal-limb accessibility and permits HOXA11 target binding in engineered limbs. **Does not show:** Developmental TF loss/ectopic HOXA11 has multiple regulatory effects; independent accessibility-state necessity remains untested. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [41] The pioneer factor SOX9 competes for epigenetic factors to switch stem cell fates. **Shows:** Engineered SOX9 reactivation opens hair-follicle enhancers and redistributes cofactors away from epidermal programs, inducing fate switching. **Does not show:** Sustained ectopic TF and cofactor competition do not prove accessibility-only activation or normal endogenous scope. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [42] ETV2 functions as a pioneer factor to regulate and reprogram the endothelial lineage. **Shows:** ETV2 binds nucleosomal DNA and recruits BRG1 during engineered endothelial differentiation/reprogramming. **Does not show:** TF/remodeler/acetylation coupled functions and engineered state restrict necessity and generalization. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [43] Pax7 pioneer factor action requires both paired and homeo DNA binding domains. **Shows:** Pax7 DNA-binding domain/motif mutants separate high-affinity pioneering from low-affinity heterochromatin binding. **Does not show:** DNA-binding/domain changes do not selectively remove accessibility while preserving activator functions. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [44] Stepwise modifications of transcriptional hubs link pioneer factor activity to a burst of transcription. **Shows:** Endogenous tagging/live imaging shows Zelda/coactivator/RNAPII cluster cascade before transcription and dispersal during elongation. **Does not show:** Cluster timing is not direct accessible-state necessity; imaging alone does not prove condensate mechanism. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC4. ### [45] Large-scale chromatin structure of inducible genes: transcription on a condensed, linear template. **Shows:** Near-endogenous-level transcription occurs on condensed multimegabase BAC transgene fibers with modest induced extension. **Does not show:** BAC arrays and large-scale compaction are not endogenous local ATAC state; evidence cannot disprove all microscopic access requirements. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [46] Transcription upregulation via force-induced direct stretching of chromatin. **Shows:** Mechanical strain upregulates DHFR BAC transgene transcription with direction/actomyosin controls. **Does not show:** Reporter and force-mediated nuclear inputs do not establish accessibility-only endogenous sufficiency. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC3, SC4. ### [47] Stepwise chromatin remodelling by a cascade of transcription initiation of non-coding RNAs. **Shows:** An endogenous fission-yeast fbp1 upstream transcription terminator blocks the ncRNA cascade and subsequent chromatin opening/activation. **Does not show:** Inserted terminator changes local cis context; locus-specific transcription-to-opening is not every genome's direction. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [48] Systematic Study of Nucleosome-Displacing Factors in Budding Yeast. **Shows:** Systematic integrated yeast motifs identify 29 nucleosome-displacing factors with binding-affinity/replication dependence. **Does not show:** Synthetic locus/motif context and occupancy endpoint are not endogenous general competence necessity. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [49] Genome access is transcription factor-specific and defined by nucleosome position. **Shows:** Defined chromosomal locus/nucleosome positioning shows TF-specific access; some factors invade internal sites and displace nucleosomes. **Does not show:** Engineered motifs demonstrate binding specificity, not accessibility-state-only endogenous output causality. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [50] Collaboration between distinct SWI/SNF chromatin remodeling complexes directs enhancer selection and activation of macrophage inflammatory genes. **Shows:** Genetic/chemical variant-specific SWI/SNF perturbations map inflammatory versus interferon transcription requirements in macrophages. **Does not show:** Signal-dependent factor/complex functions, rather than generic accessible state, carry specificity. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [51] The SWI/SNF PBAF complex facilitates REST occupancy at repressive chromatin. **Shows:** PBAF/ARID2 loss impairs REST binding and repression, showing accessibility can support a silencing factor. **Does not show:** Multifunctional complex loss does not isolate accessible-state necessity; opening need not imply activation. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. Update of: PMID 39229151. Subclaims: SC2, SC3, SC4. ### [52] Chromatin Fiber Invasion and Nucleosome Displacement by the Rap1 Transcription Factor. **Shows:** Single-molecule reconstitution shows Rap1 invades nucleosomes and cooperates with RSC for displacement. **Does not show:** Purified chromatin-fiber mechanism is Γ-limited for endogenous transcription necessity. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [53] CLOCK:BMAL1 is a pioneer-like transcription factor. **Shows:** CLOCK/BMAL1 rhythmic binding/nucleosome changes recruit other factors with heterogeneous output. **Does not show:** Rhythmic coupling and TF intervention do not isolate accessibility from clock regulation. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC4. ### [54] Mechanisms governing the pioneering and redistribution capabilities of the non-classical pioneer PU.1. **Shows:** PU.1 cannot access nucleosomal motifs in vitro but ectopic pioneering depends on activation-domain/SWI/SNF recruitment. **Does not show:** Ectopic expression and specific protein functions restrict native-state causality; linked erratum PMID32098963 details unexamined. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. Erratum in: PMID 32098963. Subclaims: SC2, SC4. ### [55] Chromatin accessibility promotes hematopoietic and leukemia stem cell activity. **Shows:** HMGN1 overexpression increases accessibility/stem-cell activity and cooperates with an AML fusion; HAT inhibition relieves the differentiation block. **Does not show:** Overexpression, leukemia mutation and histone effects cannot prove a generic accessible-state driver. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3. ### [56] Chromatin accessibility and pioneer factor FOXA1 restrict glucocorticoid receptor action in prostate cancer. **Shows:** GR uses mostly preaccessible FOXA1 sites in resistant prostate cells; FOXA1 silencing increases GR activity through NR3C1 de-repression. **Does not show:** Factor-abundance repression and p300 activity explain output; preaccess alone does not dictate receptor transcription. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [57] Epigenome editing by a CRISPR-Cas9-based acetyltransferase activates genes from promoters and enhancers. **Shows:** Targeted dCas9-p300 core acetylation activates endogenous promoter/enhancer target genes with specificity. **Does not show:** Catalytic acetylation/coactivator recruitment is more than opening; artificial tethering is not accessibility-only sufficiency. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3, SC4. ### [58] CRISPR-Mediated Synergistic Epigenetic and Transcriptional Control. **Shows:** Combined VPR/p300 epigenetic/transcriptional effectors enhance endogenous gene activation with off-target characterization. **Does not show:** Composite engineered activators cannot isolate accessible-state sufficiency and retain off-target concerns. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC3. ### [59] Enhancer switching in cell lineage priming is linked to eRNA, Brg1's AT-hook, and SWI/SNF recruitment. **Shows:** BRG1 AT-hook/eRNA association and perturbations link stage-specific SWI/SNF recruitment with enhancer/coactivator activation. **Does not show:** RNA binding/transcriptional inputs and factor functions remain coupled; this is not universal upstream opening or generic competence. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC2, SC4. ### [60] ATAC-STARR-seq reveals transcription factor-bound activators and silencers within chromatin-accessible regions of the human genome. **Shows:** ATAC-STARR reporter testing across about 101000 accessible human regions finds 30% with activator, silencer or both activity and similar silencer/activator frequencies. **Does not show:** Reporter regulatory potential is not native chromosomal competence or proof that the remaining 70% cannot regulate under other conditions. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC3. ### [61] Chromatin accessibility in the Drosophila embryo is determined by transcription factor pioneering and enhancer activation. **Shows:** Zelda motif-affinity pioneering and genetically validated patterning-factor activation generate two tiers of Drosophila enhancer accessibility. **Does not show:** Deep-model predictions require the reported genetic validation; accessibility and activation dependence are context-specific, not a universal pioneer classification. **Access/status:** Bounded original primary abstract Results/Findings/conclusion passages and linked-status metadata examined; no complete-abstract audit asserted. No complete-paper or supplement audit claimed. none_found. Subclaims: SC1, SC2, SC3, SC4.